Introduction/Overview
Natural products, as an important source of drug discovery, play an irreplaceable role in the long history of human struggle against diseases. Isolating and identifying compounds with significant biological activity from traditional medicinal plants, and elucidating their mechanisms of action, is an important paradigm in modern medicinal chemistry and pharmacology research. Among numerous natural products with medicinal value, benzophenanthridine alkaloids have attracted much attention due to their structural diversity and extensive pharmacological activities. Nitidine Chloride, as a typical benzophenanthridine alkaloid, was originally derived from the Rutaceae plant Nitidine（Zanthoxylum nitidum (Roxb) DC. was isolated and entered the field of researchers due to its significant anti malaria activity.
With the deepening of research, the pharmacological activity spectrum of Chloramphenicol has been continuously expanded, especially in the field of anti-tumor, showing great potential. Research has shown that berberine chloride can exert anticancer effects through multiple targets and pathways, including inducing tumor cell apoptosis, inhibiting signal transduction and transcription activator 3 (STAT3), interfering with DNA topoisomerase I/II α function, and regulating extracellular signal regulated kinase (ERK) and c-Src/focal adhesion kinase (FAK) related signaling pathways. In addition, the compound exhibits significant anti-inflammatory activity and can inhibit lipopolysaccharide (LPS) - induced inflammatory cytokine production by regulating the mitogen activated protein kinase (MAPK) and nuclear factor kappa B (NF - κ B) pathways. These findings reveal that berberine chloride, as a multi-target natural product, has unique advantages in treating complex diseases such as cancer and inflammation related diseases.
This article aims to provide a systematic review of the current research status of dichlorvos alkaloids, covering their chemical structure and physicochemical properties, plant sources and extraction methods, pharmacological activity, mechanism of action, drug evaluation, and clinical application prospects, in order to provide comprehensive references for the in-depth research and development of this natural product.
Chemical structure and physicochemical properties
The chemical structure of Chloramphenicol belongs to the benzophenanthridine alkaloids, and its core skeleton consists of four fused benzene rings and one nitrogen-containing phenanthridine ring. Its chemical name is 2,3-dimethoxy-12-methyl - [1,3] benzodioxolano [5,6-c] phenanthridine chloride. The quaternary ammonium nitrogen atom in this structure is the key to its alkalinity and salt formation, while two methoxy groups (- OCH ∝) and one methylenedioxy group (- O-CH ₂ - O -) substituents give it a specific electronic distribution and spatial configuration.
From the perspective of physical and chemical properties, the molecular weight of dihedrine chloride is 348.3780 g/mol. Its lipophilic water partition coefficient (LogP) is 0.6055, indicating that the compound has a certain degree of lipophilicity, but also has a certain degree of water solubility. Its topological polar surface area (TPSA) is 40.8000 Å ², which is relatively low and usually indicates that the molecule has good cell membrane permeability. The calculated water solubility parameter is 0.0718 mg/mL, indicating its limited solubility in water, which may be a challenge for its development as a drug. It is worth noting that the prediction of drug properties parameters shows that bipartite chloride has a high blood-brain barrier (BBB) penetration ability, which suggests its potential value in the treatment of central nervous system diseases, but may also bring related neurotoxic risks. In addition, the predicted results showed that it does not have hERG (human ether - à - go related gene) potassium channel inhibitory activity, reducing the risk of cardiac toxicity. However, the Ames test predicted a value of 2.4, indicating a potential genetic toxicity risk, which requires rigorous evaluation in subsequent drug development.
Plant sources and extraction methods
The main plant source of Chloramphenicol is the Zanthoxylum bungeanum plant in the Rutaceae family（Zanthoxylum nitidum (Roxb) DC.）， This plant is widely distributed in southern China, Southeast Asia, and Australia. In traditional medicine, the roots, stems, and leaves of double-sided needles are used to treat rheumatism, toothache, traumatic injuries, venomous snake bites, etc. Their analgesic, anti-inflammatory, and antibacterial effects have long been recognized by the public. Chloramphenicol is one of the main active alkaloids in Zanthoxylum bungeanum and an important material basis for its various pharmacological effects.
In addition to the two faced needle, the chloride two faced needle alkaloid is also present in other Rutaceae plants, such as Leuciscinae（Zanthoxylum avicennae）Chunye Sichuan Pepper（Zanthoxylum ailanthoides）And the Dragon Palm Blood（Toddalia asiatica）However, double-sided needles are still the main source of research and extraction at present.
The extraction of Chloramphenicol usually follows the classic process of natural product chemistry, which mainly includes the following steps:
1. Raw material pretreatment Collect the roots or stems of two needles, dry them, and crush them.
2. Rough extraction Using solvent extraction method, acidic alcohols (such as ethanol containing 0.5% -1% hydrochloric acid) or methanol are commonly used for percolation or reflux extraction. Acidic conditions facilitate the extraction of alkaloids in the form of salts.
3. enrichment After concentrating the crude extract, dissolve it in acidic water (such as 2% sulfuric acid) and filter to remove non alkaloid impurities. Then extract and remove fat soluble impurities with organic solvents such as petroleum ether and chloroform. Subsequently, the aqueous phase is adjusted to alkaline with alkaline solution (such as ammonia water) to free the alkaloids, and then extracted with organic solvents such as chloroform and ethyl acetate to obtain the total alkaloid extract.
4. Separation and purification The total alkaloid extract can be separated and purified through various chromatographic techniques to obtain high-purity chloride bipartite alkaloids. Common methods include silica gel column chromatography, alumina column chromatography, preparative thin-layer chromatography, and high-performance liquid chromatography (HPLC). In silica gel column chromatography, gradient elution systems such as chloroform methanol or petroleum ether acetone are commonly used. In recent years, modern separation techniques such as high-speed countercurrent chromatography (HSCCC) have also been applied to the efficient and rapid separation of two needle base chloride.
Pharmacological activity research
The pharmacological activity research of Chloramphenicol has expanded from its initial anti malaria activity to multiple fields such as anti-tumor, anti-inflammatory, antiviral, and anti angiogenesis. Among them, anti-tumor activity is the most in-depth and extensive research direction.
1. Antitumor activity
Nitidine chloride showed significant proliferation inhibition and cytotoxicity effects on a variety of tumor cell lines, including liver cancer, lung cancer, breast cancer, prostate cancer, colon cancer, leukemia, melanoma and osteosarcoma. Its anti-tumor mechanism is complex, involving multiple signaling pathways and molecular targets.
- Inducing cell apoptosis Chloramphenicol can induce tumor cell apoptosis through endogenous (mitochondrial) and exogenous (death receptor) pathways. It can downregulate the expression of anti apoptotic proteins BCL2 and MCL1, while upregulating the expression of pro apoptotic protein BAX, resulting in loss of mitochondrial membrane potential, release of cytochrome c, and activation of Caspase cascade reaction, ultimately leading to cell apoptosis.
- Inhibition of STAT3 signaling pathway STAT3 is a key transcription factor that is continuously activated in various tumors, promoting cell proliferation, survival, angiogenesis, and immune escape. Chloramphenicol has been shown to inhibit the phosphorylation of STAT3, thereby blocking its nuclear translocation and transcriptional activity, downregulating the expression of downstream target genes such as Cyclin D1, Survivor, VEGF, and MMP2, and exerting anti-tumor effects.
- Inhibition of DNA Topoisomerase DNA topoisomerase is an important target for anti-tumor drugs. Chloramphenicol was found to inhibit the activity of topoisomerase I (TOP1) and topoisomerase II alpha (TOP2A), stabilizing the enzyme DNA complex and causing DNA damage, thereby inhibiting DNA replication and transcription in tumor cells and ultimately inducing cell death. This mechanism is similar to the widely used camptothecin and etoposide anticancer drugs in clinical practice.
- Inhibition of MAPK and c-Src/FAK pathways The MAPK pathway (including ERK, JNK, p38) plays a critical role in cell proliferation, differentiation, and survival. Chloramphenicol can inhibit the phosphorylation of ERK, thereby blocking its pro proliferative signal. At the same time, it can also inhibit the activity of c-Src and FAK, interfere with the formation of adhesive plaques and cytoskeleton reorganization, thereby inhibiting the migration, invasion, and metastasis of tumor cells. This works together with downregulating the expression of MMP2, effectively inhibiting the metastatic potential of tumors.
- Affects other targets Chloramphenicol has also been found to inhibit the expression of hypoxia inducible factor 1 alpha (HIF1A), thereby suppressing tumor angiogenesis; By affecting the activity of estrogen receptor α (ESR1) and aromatase (CYP19A1), it shows potential therapeutic value for hormone dependent breast cancer.
2. Anti inflammatory activity
Inflammation is an important driving factor for the occurrence and development of various diseases, including cancer. Chloramphenicol shows significant anti-inflammatory activity. In the LPS stimulated macrophage model, the chloride bipartite alkaloid can significantly inhibit the production of pro-inflammatory cytokines such as tumor necrosis factor alpha (TNF - α), interleukin-6 (IL-6), and interleukin-1 β (IL-1 β). The mechanism mainly involves the regulation of two key inflammatory signaling pathways, MAPK and NF - κ B. It can inhibit LPS induced phosphorylation of p38, JNK, and ERK, while blocking the degradation of I κ B α and nuclear translocation of NF - κ B p65 subunit, thereby suppressing the expression of inflammatory mediators at the transcriptional level.
3. Other activities
In addition to anti-tumor and anti-inflammatory activities, Chloramphenicol also exhibits pharmacological activities such as anti malaria, antiviral (such as anti HIV, anti influenza virus), antifungal, anti angiogenesis, and analgesic effects. Its initial anti malarial activity was an important starting point for its discovery, and subsequent studies have confirmed that it works by interfering with the nucleic acid metabolism or heme detoxification process of malaria parasites.
Mechanism of action and molecular targets
The pharmacological activity of Chloramphenicol, especially its anti-tumor activity, is not derived from the action of a single target, but is achieved through a network regulation mode of "multi-target, multi pathway". This mode of action is a significant feature that distinguishes it from many highly selective single target drugs, and may also make it more advantageous in dealing with highly heterogeneous and complex tumor diseases.
Its core mechanism of action can be summarized as follows:
-
Direct DNA damage and topoisomerase inhibition Chloramphenicol, as a DNA intercalating agent, can insert between DNA base pairs and interfere with the template function of DNA. More importantly, it stabilizes the "cleavable complex" by inhibiting the activity of TOP1 and TOP2A, leading to DNA single or double strand breaks and triggering DNA damage response (DDR), ultimately inducing cell cycle arrest and apoptosis. This is the direct mechanism by which it exerts cytotoxicity.
-
Regulation of key signaling pathways：
- STAT3 pathway By directly or indirectly inhibiting the phosphorylation of JAK kinase or STAT3 itself, the activation of STAT3 is blocked, thereby "shutting down" a series of downstream gene expression programs that promote proliferation, survival, angiogenesis, and metastasis.
- MAPK/ERK pathway Inhibit the Ras Raf MEK ERK signaling cascade, block the transmission of mitotic signals such as growth factors, and inhibit tumor cell proliferation.
- C-Src/FAK pathway Inhibit the activity of focal adhesion kinase complex, disrupt the connection between cells and extracellular matrix, and inhibit the migration and invasion ability of cells.
- NF - κ B pathway Inhibiting the activity of I κ B kinase (IKK), preventing the degradation of I κ B α, causing NF - κ B to remain in the cytoplasm and unable to enter the nucleus to initiate transcription of pro-inflammatory and pro survival genes.
-
Regulation of apoptosis related proteins By downregulating anti apoptotic proteins (BCL2, MCL1, Survivin) and upregulating pro apoptotic proteins (BAX, BAD), the permeability balance of the mitochondrial outer membrane is disrupted, initiating the mitochondrial apoptosis pathway.
-
The impact on the tumor microenvironment By inhibiting the expression and activity of HIF1A, the secretion of vascular endothelial growth factor (VEGF) is reduced, thereby inhibiting the formation of tumor neovascularization and cutting off the nutritional supply to the tumor. Meanwhile, its anti-inflammatory activity helps reshape the tumor microenvironment and inhibit inflammation driven tumor progression.
In summary, the chloride bipartite alkaloid directly acts on DNA and topoisomerase, while simultaneously regulating multiple key signaling pathways such as STAT3, MAPK, c-Src/FAK, NF - κ B, etc., forming a synergistic anti-tumor network that can inhibit tumor cell proliferation, survival, migration, invasion, and angiogenesis from multiple levels.
Evaluation of drug properties and pharmacokinetics
Despite its remarkable pharmacological activity, the successful conversion of biphasic needle alkaloids into clinical drugs depends on their drug lethality and pharmacokinetic (ADME) properties.
From the perspective of physicochemical properties, its molecular weight (348.38) conforms to the Lipinski's Rule of Five, with a moderate LogP value (0.61) and a low TPSA (40.8 Å ²), indicating its good oral absorption potential and cell membrane permeability. However, its water solubility is poor (0.0718 mg/mL), which may limit its oral bioavailability and pose challenges for formulation development. High BBB penetration is a double-edged sword, providing the possibility for treating brain tumors or central nervous system diseases, while also increasing the risk of central neurotoxicity. The positive prediction of Ames test suggests the possibility of genetic toxicity, which is a safety issue that needs to be focused on and addressed in drug development.
The pharmacokinetic research on chloride bipartite alkaloids is currently relatively limited. Preliminary research suggests that its oral absorption may be poor and its bioavailability may not be high. In the body, it may undergo extensive metabolism, mainly involving cytochrome P450 enzyme mediated oxidative metabolism (such as demethylation) and glucuronic acid binding reactions. It is widely distributed and can enter various tissues and organs. The main pathways of excretion may be through bile and feces. Due to its poor water solubility and potential metabolic instability, how to improve its bioavailability is currently the focus of research. Strategies such as nanomedicine (such as liposomes, polymer micelles, nanocrystals), phospholipid complexes, and prodrug design are being explored to improve their solubility and pharmacokinetic properties.
Clinical application prospects and prospects
Chloramphenicol, as a natural product with multi-target action characteristics, has shown broad application prospects in the field of tumor treatment, especially for tumor types that have developed resistance to traditional chemotherapy drugs or have high metastatic potential. Its unique STAT3 and c-Src/FAK inhibitory activities give it potential advantages in inhibiting tumor metastasis. In addition, its anti-inflammatory activity also suggests that it can be used to treat chronic inflammation related diseases, and even as a cancer chemopreventive agent.
However, achieving its clinical translation still faces many challenges:
1. Toxicity issue The genetic toxicity risk indicated by a positive Ames test needs to be comprehensively evaluated. The neurotoxicity that high BBB penetration may bring also needs to be carefully examined in animal models. The therapeutic window needs to be clearly defined.
2. bioavailability The low oral bioavailability caused by poor water solubility and possible metabolic first pass effects is the main bottleneck limiting its clinical application. Developing efficient and safe drug delivery systems is an urgent task.
3. Deep analysis of the mechanism of action Although multiple targets have been identified, their precise molecular binding patterns, direct target proteins, and synergistic relationships between different targets still need further clarification. This helps guide structural optimization and combination therapy strategies.
4. Combination therapy strategy Given its multi-target nature, the combined use of chloride bipartite alkaloids with other chemotherapy drugs, targeted drugs, or immune checkpoint inhibitors may produce synergistic effects and reduce the occurrence of drug resistance. For example, the combination with cisplatin, paclitaxel, or PD-1/PD-L1 inhibitors is worth further exploration.
5. structural optimization Using chloride bipartite alkaloids as lead compounds, structural modification is carried out through medicinal chemical methods in order to obtain derivatives with higher activity, lower toxicity, and better pharmacokinetic properties, which is an important way to promote their clinical application.
Conclusion
Chloramphenicol, as a benzophenanthridine alkaloid derived from the traditional medicinal plant Zanthoxylum bungeanum, has become a shining star in the field of natural product drug research due to its unique chemical structure and multi-target pharmacological activity, especially its significant anti-tumor and anti-inflammatory effects. It forms a synergistic network by inhibiting multiple key targets and signaling pathways such as DNA topoisomerase, STAT3, MAPK, c-Src/FAK, demonstrating enormous potential in combating complex diseases such as cancer.
Although there are still challenges in drug formulation, such as water solubility, potential genetic toxicity, and pharmacokinetic properties, these issues are expected to be addressed through modern drug chemical modifications, advanced drug delivery system development, and rational combination therapy strategies. In depth research on the alkaloids of Chinese herbal medicine Zanthoxylum bungeanum not only helps to reveal the pharmacological substance basis of traditional Chinese medicine Zanthoxylum bungeanum, but also provides valuable lead compounds for the development of innovative drugs with independent intellectual property rights in China. In the future, with a deeper understanding of its mechanism of action and breakthroughs in related technological bottlenecks, chloride bipartite alkaloids and their derivatives are expected to play an important role in the treatment of major diseases such as tumors, achieving a magnificent transformation from natural products to clinical drugs.
